Ownership history in COMMONWEALTH EQUITY SERVICES, LLC · 7 quarters on record
This page tracks every 13F SEC filing in which COMMONWEALTH EQUITY SERVICES, LLC reported a position in LANTERN PHARMA INC (LTRN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 18,161 | — | 0% | 0.00% | $79K | $4.35 |
| 2025 Q2 | ADDED | 18,161 | +5,464 | +43.0% | 0.00% | $57K | $3.16 |
| 2025 Q1 | REDUCED | 12,697 | -46,151 | -78.4% | 0.00% | $45K | $3.54 |
| 2023 Q4 | ADDED | 58,848 | +43,480 | +282.9% | 0.00% | $252K | $4.28 |
| 2023 Q3 | REDUCED | 15,368 | -1,445 | -8.6% | 0.00% | $52K | $3.41 |
| 2023 Q2 | REDUCED | 16,813 | -3,373 | -16.7% | 0.00% | $95K | $5.64 |
| 2023 Q1 | INITIATED | 20,186 | — | — | 0.00% | $97K | $4.83 |
As of 2025 Q4 — sorted by position size